Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jun;115(4):653–659. doi: 10.1111/j.1476-5381.1995.tb14982.x

Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung.

H Lal 1, B Woodward 1, K I Williams 1
PMCID: PMC1908493  PMID: 7582486

Abstract

1. Endothelin (ET) receptors within the vasculature and airways were studied in a rat perfused lung model in which pulmonary perfusion pressure (PPP), pulmonary inflation pressure (PIP) and lung weight were continuously monitored. 2. The vascular potencies of ETs (ET-1 > ET-2 > ET-3) suggest an action via ETA receptors. This was confirmed by use of the antagonist, BQ123 (2 microM). The vasoconstrictor effects of sarafotoxin 6c (SX6C) also indicated the presence of ETB receptors. 3. Lung weight increases induced by ETs appeared to be a consequence of their vasoconstrictor potencies. The mixed ET receptor antagonist, bosentan (5 microM), markedly attenuated the responses of ET-1 and SX6C on PPP and lung weight, further implicating activation of both ETA and ETB receptors in these responses. 4. Endothelin-1 (ET-1) induced an accumulation of albumin-bound Evans blue dye in orthogradely perfused lungs. Retrograde perfusion attenuated the extravasation and increase in lung weight due to ET-1 but significantly augmented those induced by SX6C. 5. The bronchoconstrictor actions of ETs (ET-1 = ET-2 = ET-3) and SX6C suggest this is an ETB-mediated response. However SX6C was more potent than ETs and the dose-response curve was significantly steeper and achieved a higher maximum. 6. Indomethacin did not affect the vascular or bronchial responses to ET-1 or SX6C. 7. These findings indicate that rat pulmonary vasculature contains both ETA and ETB receptors. Retrograde perfusion suggests that ETB receptors are located arterially whereas ETA receptors are predominantly venous in distribution.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Battistini B., Germain M., Fournier A., Sirois P. Structure-activity relationships of ET-1 and selected analogues in the isolated guinea pig trachea: evidence for the existence of different ETB receptor subtypes. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S219–S224. doi: 10.1097/00005344-199322008-00059. [DOI] [PubMed] [Google Scholar]
  3. Battistini B., Warner T. D., Fournier A., Vane J. R. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065. Br J Pharmacol. 1994 Apr;111(4):1009–1016. doi: 10.1111/j.1476-5381.1994.tb14844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Black P. N., Ghatei M. A., Takahashi K., Bretherton-Watt D., Krausz T., Dollery C. T., Bloom S. R. Formation of endothelin by cultured airway epithelial cells. FEBS Lett. 1989 Sep 11;255(1):129–132. doi: 10.1016/0014-5793(89)81075-0. [DOI] [PubMed] [Google Scholar]
  5. Bonvallet S. T., Oka M., Yano M., Zamora M. R., McMurtry I. F., Stelzner T. J. BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol. 1993 Jul;22(1):39–43. doi: 10.1097/00005344-199307000-00007. [DOI] [PubMed] [Google Scholar]
  6. Clozel M., Breu V., Gray G. A., Kalina B., Löffler B. M., Burri K., Cassal J. M., Hirth G., Müller M., Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994 Jul;270(1):228–235. [PubMed] [Google Scholar]
  7. D'Orléans-Juste P., Claing A., Warner T. D., Yano M., Télémaque S. Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat. Br J Pharmacol. 1993 Oct;110(2):687–692. doi: 10.1111/j.1476-5381.1993.tb13866.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ercan Z. S., Kilinç M., Yazar O., Korkusuz P., Türker R. K. Endothelin-1-induced oedema in rat and guinea-pig isolated perfused lungs. Arch Int Pharmacodyn Ther. 1993 May-Jun;323:74–84. [PubMed] [Google Scholar]
  9. Filep J. G., Földes-Filep E., Rousseau A., Fournier A., Sirois P., Yano M. Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptor. Eur J Pharmacol. 1992 Aug 25;219(2):343–344. doi: 10.1016/0014-2999(92)90318-x. [DOI] [PubMed] [Google Scholar]
  10. Filep J. G., Sirois M. G., Földes-Filep E., Rousseau A., Plante G. E., Fournier A., Yano M., Sirois P. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors. Br J Pharmacol. 1993 Jul;109(3):880–886. doi: 10.1111/j.1476-5381.1993.tb13657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hay D. W., Luttmann M. A., Hubbard W. C., Undem B. J. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol. 1993 Nov;110(3):1175–1183. doi: 10.1111/j.1476-5381.1993.tb13938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hisaki K., Matsumura Y., Maekawa H., Fujita K., Takaoka M., Morimoto S. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme. Am J Physiol. 1994 Feb;266(2 Pt 2):H422–H428. doi: 10.1152/ajpheart.1994.266.2.H422. [DOI] [PubMed] [Google Scholar]
  13. Horgan M. J., Pinheiro J. M., Malik A. B. Mechanism of endothelin-1-induced pulmonary vasoconstriction. Circ Res. 1991 Jul;69(1):157–164. doi: 10.1161/01.res.69.1.157. [DOI] [PubMed] [Google Scholar]
  14. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  15. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karne S., Jayawickreme C. K., Lerner M. R. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem. 1993 Sep 5;268(25):19126–19133. [PubMed] [Google Scholar]
  17. Kloog Y., Ambar I., Sokolovsky M., Kochva E., Wollberg Z., Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science. 1988 Oct 14;242(4876):268–270. doi: 10.1126/science.2845579. [DOI] [PubMed] [Google Scholar]
  18. Kumar C., Mwangi V., Nuthulaganti P., Wu H. L., Pullen M., Brun K., Aiyar H., Morris R. A., Naughton R., Nambi P. Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem. 1994 May 6;269(18):13414–13420. [PubMed] [Google Scholar]
  19. Lal H., Woodward B., Williams K. I. Differential effects of agents on bronchial and vascular tone and lung weight in the rat isolated perfused lung. Pulm Pharmacol. 1994 Aug;7(4):271–278. doi: 10.1006/pulp.1994.1031. [DOI] [PubMed] [Google Scholar]
  20. MacLean M. R., McCulloch K. M., Baird M. Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol. 1994 May;23(5):838–845. doi: 10.1097/00005344-199405000-00022. [DOI] [PubMed] [Google Scholar]
  21. McKay K. O., Black J. L., Armour C. L. The mechanism of action of endothelin in human lung. Br J Pharmacol. 1991 Feb;102(2):422–428. doi: 10.1111/j.1476-5381.1991.tb12189.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Noguchi K., Noguchi Y., Hirose H., Nishikibe M., Ihara M., Ishikawa K., Yano M. Role of endothelin ETB receptors in bronchoconstrictor and vasoconstrictor responses in guinea-pigs. Eur J Pharmacol. 1993 Mar 16;233(1):47–51. doi: 10.1016/0014-2999(93)90347-k. [DOI] [PubMed] [Google Scholar]
  23. O'Donnell S. R., Wanstall J. C., Zeng X. P. Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations. J Pharmacol Exp Ther. 1990 Mar;252(3):1318–1323. [PubMed] [Google Scholar]
  24. Palmer M. A., Piper P. J., Vane J. R. Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs. Br J Pharmacol. 1973 Oct;49(2):226–242. doi: 10.1111/j.1476-5381.1973.tb08368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Raffestin B., Adnot S., Eddahibi S., Macquin-Mavier I., Braquet P., Chabrier P. E. Pulmonary vascular response to endothelin in rats. J Appl Physiol (1985) 1991 Feb;70(2):567–574. doi: 10.1152/jappl.1991.70.2.567. [DOI] [PubMed] [Google Scholar]
  26. Rodman D. M., Stelzner T. J., Zamora M. R., Bonvallet S. T., Oka M., Sato K., O'Brien R. F., McMurtry I. F. Endothelin-1 increases the pulmonary microvascular pressure and causes pulmonary edema in salt solution but not blood-perfused rat lungs. J Cardiovasc Pharmacol. 1992 Oct;20(4):658–663. doi: 10.1097/00005344-199210000-00021. [DOI] [PubMed] [Google Scholar]
  27. Saida K., Mitsui Y., Ishida N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity. J Biol Chem. 1989 Sep 5;264(25):14613–14616. [PubMed] [Google Scholar]
  28. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  29. Skolovsky M., Galron R., Kloog Y., Bdolah A., Indig F. E., Blumberg S., Fleminger G. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4702–4706. doi: 10.1073/pnas.87.12.4702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Takasuka T., Akiyama N., Horii I., Furuichi Y., Watanabe T. Different stability of ligand-receptor complex formed with two endothelin receptor species, ETA and ETB. J Biochem. 1992 Jun;111(6):748–753. doi: 10.1093/oxfordjournals.jbchem.a123830. [DOI] [PubMed] [Google Scholar]
  31. Uchida Y., Saotome M., Nomura A., Ninomiya H., Ohse H., Hirata F., Hasegawa S. Endothelin-1-induced relaxation of guinea pig trachealis muscles. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S210–S212. doi: 10.1097/00005344-199100177-00060. [DOI] [PubMed] [Google Scholar]
  32. Webb D. J. Endothelin receptors cloned, endothelin converting enzyme characterized and pathophysiological roles for endothelin proposed. Trends Pharmacol Sci. 1991 Feb;12(2):43–46. doi: 10.1016/0165-6147(91)90492-b. [DOI] [PubMed] [Google Scholar]
  33. White D. G., Cannon T. R., Garratt H., Mundin J. W., Sumner M. J., Watts I. S. Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction. J Cardiovasc Pharmacol. 1993;22 (Suppl 8):S144–S148. doi: 10.1097/00005344-199322008-00039. [DOI] [PubMed] [Google Scholar]
  34. White D. G., Garratt H., Mundin J. W., Sumner M. J., Vallance P. J., Watts I. S. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol. 1994 May 23;257(3):307–310. doi: 10.1016/0014-2999(94)90144-9. [DOI] [PubMed] [Google Scholar]
  35. Williams D. L., Jr, Jones K. L., Pettibone D. J., Lis E. V., Clineschmidt B. V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 1991 Mar 15;175(2):556–561. doi: 10.1016/0006-291x(91)91601-8. [DOI] [PubMed] [Google Scholar]
  36. Wu-Wong J. R., Chiou W. J., Naugles K. E., Jr, Opgenorth T. J. Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist. Life Sci. 1994;54(22):1727–1734. doi: 10.1016/0024-3205(94)00613-x. [DOI] [PubMed] [Google Scholar]
  37. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES